Education
About Us
Working with TipRanks
Follow Us
CBD Life Sciences (CBDL)
OTHER OTC:CBDL
Total Valuation
CBD Life Sciences has a market cap or net worth of $569.70K. The enterprise value is -$143.90K.
Market Cap$569.70K
Enterprise Value-$143.90K
Share Statistics
CBD Life Sciences has 5,696,998,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,696,998,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CBD Life Sciences’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -13.26%.
Return on Equity (ROE)-0.06
Return on Assets (ROA)-0.06
Return on Invested Capital (ROIC)-13.26%
Return on Capital Employed (ROCE)-0.13
Revenue Per Employee32.77K
Profits Per Employee-16.31K
Employee Count3
Asset Turnover0.12
Inventory Turnover1.62
Valuation Ratios
The current PE Ratio of CBD Life Sciences is ―. CBD Life Sciences’s PEG ratio is 0.17.
PE Ratio―
PS Ratio8.36
PB Ratio1.07
Price to Fair Value1.07
Price to FCF-5.91
Price to Operating Cash Flow-1.94
PEG Ratio0.17
Income Statement
In the last 12 months, CBD Life Sciences had revenue of 98.32K and earned -48.93K in profits. Earnings per share was 0.00.
Revenue98.32K
Gross Profit41.49K
Operating Income-101.70K
Pretax Income-48.93K
Net Income-48.93K
EBITDA-101.70K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -211.94K and capital expenditures 0.00, giving a free cash flow of -211.94K billion.
Operating Cash Flow-211.94K
Free Cash Flow-211.94K
Free Cash Flow per Share>-0.01
Dividends & Yields
CBD Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.73
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
CBD Life Sciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
CBD Life Sciences as a current ratio of 15.12, with Debt / Equity ratio of 0.00%
Current Ratio15.12
Quick Ratio14.21
Debt to Market Cap0.00
Net Debt to EBITDA3.26
Interest Coverage Ratio0.00
Taxes
In the past 12 months, CBD Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CBD Life Sciences EV to EBITDA ratio is -4.82, with an EV/FCF ratio of -3.52.
EV to Sales4.99
EV to EBITDA-4.82
EV to Free Cash Flow-3.52
EV to Operating Cash Flow-3.52
Balance Sheet
CBD Life Sciences has $127.09K in cash and marketable securities with $0.00 in debt, giving a net cash position of $127.09K billion.
Cash & Marketable Securities$127.09K
Total Debt$0.00
Net Cash$127.09K
Net Cash Per Share<$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is -9.89%, with operating margin of -103.44%, and net profit margin of -49.76%.
Gross Margin-9.89%
Operating Margin-103.44%
Pretax Margin-49.76%
Net Profit Margin-49.76%
EBITDA Margin-103.44%
EBIT Margin-103.44%
Analyst Forecast
The average price target for CBD Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―